$154 Million is the total value of Michelson Medical Research Foundation, Inc.'s 31 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HYG | New | ISHARES TRiboxx hi yd etf | $18,785,222 | – | 255,130 | +100.0% | 12.17% | – |
| VNQ | New | VANGUARD INDEX FDSreal estate etf | $18,680,070 | – | 226,480 | +100.0% | 12.10% | – |
| HDV | New | ISHARES TRcore high dv etf | $13,688,797 | – | 131,320 | +100.0% | 8.87% | – |
| IVE | New | ISHARES TRs&p 500 val etf | $13,503,841 | – | 93,085 | +100.0% | 8.75% | – |
| IVV | New | ISHARES TRcore s&p500 etf | $12,947,493 | – | 33,699 | +100.0% | 8.38% | – |
| VEA | New | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $12,837,574 | – | 305,875 | +100.0% | 8.31% | – |
| VWO | New | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $9,223,837 | – | 236,630 | +100.0% | 5.97% | – |
| AVB | New | AVALONBAY CMNTYS INC | $7,185,217 | – | 44,485 | +100.0% | 4.65% | – |
| IBB | New | ISHARES TRishares biotech | $5,697,330 | – | 43,395 | +100.0% | 3.69% | – |
| ARE | New | ALEXANDRIA REAL ESTATE EQ IN | $5,423,294 | – | 37,230 | +100.0% | 3.51% | – |
| BSV | New | VANGUARD BD INDEX FDSshort trm bond | $5,417,525 | – | 71,965 | +100.0% | 3.51% | – |
| PLD | New | PROLOGIS INC. | $4,780,316 | – | 42,405 | +100.0% | 3.10% | – |
| ERF | New | ENERPLUS CORP | $3,449,163 | – | 195,420 | +100.0% | 2.23% | – |
| OAS | New | CHORD ENERGY CORPORATION | $2,790,924 | – | 20,400 | +100.0% | 1.81% | – |
| TALO | New | TALOS ENERGY INC | $2,639,046 | – | 139,780 | +100.0% | 1.71% | – |
| XBI | New | SPDR SER TRs&p biotech | $2,597,900 | – | 31,300 | +100.0% | 1.68% | – |
| CRC | New | CALIFORNIA RES CORP | $2,543,160 | – | 58,450 | +100.0% | 1.65% | – |
| PFF | New | ISHARES TRpfd and incm sec | $2,502,544 | – | 81,970 | +100.0% | 1.62% | – |
| New | CRESCENT ENERGY COMPANY | $1,872,430 | – | 156,166 | +100.0% | 1.21% | – | |
| BXP | New | BOSTON PROPERTIES INC | $1,468,851 | – | 21,735 | +100.0% | 0.95% | – |
| BKLN | New | INVESCO EXCH TRADED FD TR IIsr ln etf | $1,396,656 | – | 92,530 | +100.0% | 0.90% | – |
| NML | New | NEUBERGER BERMAN MLP & ENERG | $771,708 | – | 115,872 | +100.0% | 0.50% | – |
| New | RICE ACQUISITION CORP II | $518,975 | – | 51,030 | +100.0% | 0.34% | – | |
| WPCA | New | WARBURG PINCUS CAPTAL CORP I | $514,141 | – | 50,905 | +100.0% | 0.33% | – |
| WPCB | New | WARBURG PINCUS CAPTAL CORP I | $513,803 | – | 50,922 | +100.0% | 0.33% | – |
| MSDA | New | MSD ACQUISITION CORP | $514,893 | – | 51,030 | +100.0% | 0.33% | – |
| ROSS | New | ROSS ACQUISITION CORP II | $514,653 | – | 50,855 | +100.0% | 0.33% | – |
| LDHA | New | LDH GROWTH CORP I | $511,818 | – | 50,826 | +100.0% | 0.33% | – |
| New | ORION BIOTECH OPPORTUNTES CO | $510,339 | – | 50,780 | +100.0% | 0.33% | – | |
| ANAC | New | ARCTOS NORTHSTAR ACQUIS CORP | $500,474 | – | 49,601 | +100.0% | 0.32% | – |
| RSX | New | VANECK ETF TRUSTvaneck russia et | $102,900 | – | 105,000 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD TAX-MANAGED FDS | 7 | Q2 2024 | 15.3% |
| VANGUARD INTL EQUITY INDEX F | 7 | Q2 2024 | 8.9% |
| ISHARES TR | 7 | Q2 2024 | 8.7% |
| ISHARES TR | 7 | Q2 2024 | 8.4% |
| AVALONBAY CMNTYS INC | 7 | Q2 2024 | 7.4% |
| ISHARES TR | 7 | Q2 2024 | 5.1% |
| PROLOGIS INC. | 7 | Q2 2024 | 4.1% |
| ALEXANDRIA REAL ESTATE EQ IN | 7 | Q2 2024 | 4.3% |
| SPDR SER TR | 7 | Q2 2024 | 2.5% |
| CRESCENT ENERGY COMPANY | 7 | Q2 2024 | 1.6% |
View Michelson Medical Research Foundation, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
View Michelson Medical Research Foundation, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.